Prof Giuseppe Curigliano from the European Institute of Oncology in Milan, Italy, and Dr Priyanka Sharma from the University of Kansas Cancer Center in Westwood, Kansas, discuss the implications of clinical findings in breast cancer recently presented at the 2025 ESMO Annual Meeting.&nbsp;CME information and select publications <a href="https://www.researchtopractice.com/PostESMOBreast25" rel="noopener noreferrer" target="_blank">here</a>.

<description>&lt;p&gt;Prof Giuseppe Curigliano from the European Institute of Oncology in Milan, Italy, and Dr Priyanka Sharma from the University of Kansas Cancer Center in Westwood, Kansas, discuss the implications of clinical findings in breast cancer recently presented at the 2025 ESMO Annual Meeting.&amp;nbsp;&lt;/p&gt;&lt;p&gt;CME information and select publications &lt;a href="https://www.researchtopractice.com/PostESMOBreast25" rel="noopener noreferrer" target="_blank"&gt;here&lt;/a&gt;. &lt;/p&gt;</description>

Breast Cancer — Highlights from the 2025 ESMO Annual Meeting

Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, summarizes the treatment landscape for patients with breast cancer and discusses the implications of recently presented clinical findings from the ESMO Congress 2025.&nbsp;CME information and select publications <a href="https://www.researchtopractice.com/PostESMOBreast25/Micro/3" rel="noopener noreferrer" target="_blank">here</a>.

<description>&lt;p&gt;Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, summarizes the treatment landscape for patients with breast cancer and discusses the implications of recently presented clinical findings from the ESMO Congress 2025.&amp;nbsp;&lt;/p&gt;&lt;p&gt;CME information and select publications &lt;a href="https://www.researchtopractice.com/PostESMOBreast25/Micro/3" rel="noopener noreferrer" target="_blank"&gt;here&lt;/a&gt;. &lt;/p&gt;</description>

Breast Cancer — Microlearning Activity Issue 3 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates

Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, summarizes the treatment landscape for patients with breast cancer and discusses the implications of recently presented clinical findings from the ESMO Congress 2025.&nbsp;CME information and select publications <a href="https://www.researchtopractice.com/PostESMOBreast25/Micro/2" rel="noopener noreferrer" target="_blank">here</a>.

<description>&lt;p&gt;Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, summarizes the treatment landscape for patients with breast cancer and discusses the implications of recently presented clinical findings from the ESMO Congress 2025.&amp;nbsp;&lt;/p&gt;&lt;p&gt;CME information and select publications &lt;a href="https://www.researchtopractice.com/PostESMOBreast25/Micro/2" rel="noopener noreferrer" target="_blank"&gt;here&lt;/a&gt;. &lt;/p&gt;</description>

Breast Cancer — Microlearning Activity 2 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates

Dr Rinath M Jeselsohn and Dr Joyce O’Shaughnessy review current literature and datasets exploring the use of oral selective estrogen receptor degraders for the management of metastatic breast cancer.&nbsp;CME information and select publications <a href="https://www.researchtopractice.com/OralSERDSmBC2025/2" rel="noopener noreferrer" target="_blank">here</a>.

<description>&lt;p&gt;Dr Rinath M Jeselsohn and Dr Joyce O’Shaughnessy review current literature and datasets exploring the use of oral selective estrogen receptor degraders for the management of metastatic breast cancer.&amp;nbsp;&lt;/p&gt;&lt;p&gt;CME information and select publications &lt;a href="https://www.researchtopractice.com/OralSERDSmBC2025/2" rel="noopener noreferrer" target="_blank"&gt;here&lt;/a&gt;. &lt;/p&gt;</description>

Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2

Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, summarizes the treatment landscape for patients with breast cancer and discusses the implications of recently presented clinical findings from the ESMO Congress 2025.&nbsp;CME information and select publications <a href="https://www.researchtopractice.com/PostESMOBreast25/Micro/1" rel="noopener noreferrer" target="_blank">here</a>.

<description>&lt;p&gt;Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, summarizes the treatment landscape for patients with breast cancer and discusses the implications of recently presented clinical findings from the ESMO Congress 2025.&amp;nbsp;&lt;/p&gt;&lt;p&gt;CME information and select publications &lt;a href="https://www.researchtopractice.com/PostESMOBreast25/Micro/1" rel="noopener noreferrer" target="_blank"&gt;here&lt;/a&gt;. &lt;/p&gt;</description>

Breast Cancer — Microlearning Activity 1 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.

This series bridges the gap between research and patient care by providing on-going access to the perspectives and opinions of national and international breast cancer research leaders.

Breast Cancer Update

Details

Recent Episodes